SOURCE: Implant Sciences

Implant Sciences

December 15, 2011 07:00 ET

Implant Sciences Sells Over $200,000 of Quantum Sniffer Portable Explosives Trace Detectors for Building Security in Mexico

WILMINGTON, MA--(Marketwire - Dec 15, 2011) - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, announced today it has received an order worth over $200,000 for multiple units of its Quantum Sniffer™ QS-H150 portable explosives trace detector to be deployed for building security in Mexico.

Implant Sciences has been selling the QS-H150 in Mexico since 2008, where the system is used daily for a variety of applications, including airport security. The Mexican market for security equipment and services was estimated at $1.2 billion in 2006, with imports accounting for $503 million of the total, according to a report published by the Massachusetts Office of International Trade and Investment. The report also cited the 'explosives detection' category as having one of the 'best prospects' in the security sector.

"We are pleased with the continued success of our products in Mexico. Latin America and South America are key markets for us and Mexico is of primary importance. Meeting the growing demand for explosives trace detection equipment in Mexico helps create greater security for a valued U.S. ally," stated Glenn D. Bolduc, President and CEO of Implant Sciences.

"Our global distribution network continues to generate the sales momentum we seek. Having recently sold and shipped substantial orders to Asia and the Middle East, we are pleased to deliver additional QS-H150s into Latin America, a strategic growth market," added Bruce Bower, Implant Sciences' Senior Vice President of Sales and Marketing.

About the Quantum Sniffer™ QS-H150

The QS-H150 is a handheld explosives trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives. The QS-H150 uses no radioactive materials and features a low-maintenance design that is self-calibrating and self-clearing, providing very high levels of operational availability.

About the Quantum Sniffer™ QS-B220

The QS-B220, introduced in May 2011, is a benchtop explosives and narcotics trace detector that uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, plus narcotic substances. The QS-B220 continues the Implant Sciences tradition of freedom from radioactive materials, low total cost of ownership, and high operational availability.

About Implant Sciences

Implant Sciences develops, manufactures, and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed innovative proprietary technologies used in its explosives and narcotics trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences products have been deployed in a wide range of security environments including airports, subways, railways, cargo facilities, nuclear power plants, police departments, military units, government buildings, and financial institutions. The QS-H150 and QS-B220 are Department of Homeland Security (DHS) Qualified Anti-Terrorism Technologies under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    Email Contact


    Investor Contact:
    Laurel Moody
    Email Contact